New international consensus addresses a long-standing gap in diabetes care with practical, evidence-informed guidance for clinicians An international panel of 35 experts from 13 countries has published the world’s first…
CoEHAR and DAHUDER (Internal Medicine Specialists Association in Turkey) continue their commitment to advancing metabolic research and international medical education with the fifth edition of the "Type 2 Diabetes in…
A new CoEHAR systematic review and meta-analysis, published in Internal and Emergency Medicine, has examined the available evidence on the relationship between electronic cigarette use and metabolic health outcomes, including…
A new scientific review co-authored by CoEHAR researchers explores the role of finerenone, a medication used to protect the heart and kidneys in high-risk patients with diabetes and chronic kidney…
Smoking remains one of the most important — and most neglected — modifiable risk factors in the management of type 2 diabetes (T2D). Despite strong evidence that quitting reduces cardiovascular…
CoEHAR is proud to announce that Dr. Rossella Cannarella has been awarded one of the prestigious Tobacco Harm Reduction Scholarships (THRSP) — an international program supporting early-career researchers engaged in…
For people living with diabetes, smoking represents much more than a harmful habit — it is a major driver of cardiovascular complications and long-term metabolic damage. Quitting is one of…
For two days, on November 10 and 11, Catania became the world capital of research on diabetes and smoking. At the Plaza Hotel, the first Delphi Consensus Meeting of the…
Following the success of the first edition held in May 2025, the University of Catania and CoEHAR – Center of Excellence for the Acceleration of Harm Reduction – together with…
On May 30–31, 2025, the international scientific conference “TYPE 2 Diabetes in Internal Medicine Practice: Experience Sharings 1” was held in Catania, at the Romano Palace Hotel, bringing together over…
